Detalhe da pesquisa
1.
Breast density, benign breast disease, and risk of breast cancer over time.
Eur Radiol
; 31(7): 4839-4847, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33409776
2.
Assessment of early therapy discontinuation and health-related quality of life in breast cancer patients treated with aromatase inhibitors: B-ABLE cohort study.
Breast Cancer Res Treat
; 177(1): 53-60, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31127467
3.
Changes in metabolic risk, insulin resistance, leptin and adiponectin following a lifestyle intervention in overweight and obese breast cancer survivors.
Eur J Cancer Care (Engl)
; 27(4): e12861, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29869823
4.
Non-canonical NF-κB pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinoma.
Br J Cancer
; 115(3): 322-31, 2016 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-27404455
5.
An overview of randomized clinical trials in metastatic breast cancer: variables affecting regulatory drug approval.
Anticancer Drugs
; 25(9): 992-7, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24892723
6.
Genetic determinants of aromatase inhibitor-related arthralgia: the B-ABLE cohort study.
Breast Cancer Res Treat
; 140(2): 385-95, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23868189
7.
Vitamin D threshold to prevent aromatase inhibitor-related bone loss: the B-ABLE prospective cohort study.
Breast Cancer Res Treat
; 133(3): 1159-67, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22434523
8.
Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: a prospective cohort study.
Breast Cancer Res Treat
; 125(3): 869-78, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20665105
9.
Phase I/II study of biweekly vinorelbine and oxaliplatin as first-line treatment in patients with metastatic breast cancer.
Anticancer Drugs
; 22(3): 283-9, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21150776
10.
Mitogen-activated protein kinase phosphatase-1 in human breast cancer independently predicts prognosis and is repressed by doxorubicin.
Clin Cancer Res
; 15(10): 3530-9, 2009 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19417026
11.
Effectiveness and safety of a novel dexamethasone mouthwash formulation in managing stomatitis in cancer patients.
Farm Hosp
; 45(1): 41-44, 2020 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33443477
12.
Thromboembolic, cardiovascular and overall mortality risks of aromatase inhibitors, compared with tamoxifen treatment: an outpatient-register-based retrospective cohort study.
Ther Adv Med Oncol
; 12: 1758835920909660, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32231712
13.
Increased Fracture Risk in Women Treated With Aromatase Inhibitors Versus Tamoxifen: Beneficial Effect of Bisphosphonates.
J Bone Miner Res
; 35(2): 291-297, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31596961
14.
A single-nucleotide polymorphism in the aromatase gene is associated with the efficacy of the aromatase inhibitor letrozole in advanced breast carcinoma.
Clin Cancer Res
; 14(3): 811-6, 2008 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18245543
15.
Epidemiologic study to assess patient involvement in choice of adjuvant chemotherapy for breast cancer (PROSA Study).
Clin Transl Oncol
; 11(4): 221-7, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19380299
16.
High Numbers of Circulating CD57+ NK Cells Associate with Resistance to HER2-Specific Therapeutic Antibodies in HER2+ Primary Breast Cancer.
Cancer Immunol Res
; 7(8): 1280-1292, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31189644
17.
Alkylphenolic compounds and risk of breast and prostate cancer in the MCC-Spain study.
Environ Int
; 122: 389-399, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30553564
18.
Vitamin D levels in Mediterranean breast cancer patients compared with those in healthy women.
Maturitas
; 116: 83-88, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30244785
19.
Bone health evaluation one year after aromatase inhibitors completion.
Bone
; 117: 54-59, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30223134
20.
Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations.
Genome Med
; 10(1): 25, 2018 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29592813